| View |
|
DR-XY43597
|
Terlipressin acetate
|
Glypressin
|
100mcg/mL
|
Solution For Injection (IV)
|
Vasopressin and analogues
|
Zentiva K.S.
|
Czech Republic
|
Renewal
|
18 May 2024
|
06 August 2029
|
| View |
|
DR-XY43598
|
Losartan Potassium + Hydrochlorothiazide
|
Vamzar Plus
|
50 mg/12.5 mg
|
Fim-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
26 April 2024
|
06 August 2029
|
| View |
|
DR-XY43601
|
Clindamycin Phosphate
|
Clinmyn
|
150mg/mL
|
Solution For Injection
|
Antibacterial (Lincosamide)
|
Samjin Pharmaceutical, Co. Ltd.
|
South Korea
|
Automatic Renewal
|
12 December 2022
|
08 August 2027
|
| View |
|
DR-XY43602
|
Omeprazole (as Sodium)
|
Ometor
|
40mg
|
Lyophilized Powder For Injection (IV)
|
Proton Pump Inhibitor
|
Cisen Pharmaceutical Co., Ltd
|
China
|
Renewal
|
25 July 2024
|
06 August 2029
|
| View |
|
DR-XY43607
|
Paclitaxel
|
Vexel-30
|
6mg/mL (30mg/5mL)
|
Concentrate For Solution For Iv Infusion
|
Antineoplastic
|
Admac Lifesciences
|
India
|
Renewal
|
16 November 2023
|
06 August 2029
|
| View |
|
DR-XY43608
|
Paclitaxel
|
Vexel-100
|
6mg/mL (100mg/16.7mL)
|
Concentrate For Solution For Iv Infusion
|
Antineoplastic
|
Admac Lifesciences
|
India
|
Renewal
|
16 November 2023
|
06 August 2029
|
| View |
|
DR-XY43610
|
Ondansetron (as hydrochloride)
|
Ondavell
|
4mg
|
Film Coated Tablet
|
Antiemetic
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
08 May 2024
|
11 August 2029
|
| View |
|
DR-XY43611
|
Ondansetron (as hydrochloride dihydrate)
|
Ondavell
|
2mg/mL (4mg/2mL)
|
Solution For Injection (IM/IV)
|
Antiemetic
|
PT. Novell Pharmaceutical Laboratories
|
Indonesia
|
Renewal
|
21 April 2024
|
11 August 2029
|
| View |
|
DR-XY43612
|
Multivitamins + Minerals
|
Centrum Silver Advance
|
(see formulation on reverse side)
|
Film-Coated Tablet
|
Vitamins and Minerals
|
Wyeth Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
19 April 2022
|
12 May 2027
|
| View |
|
DR-XY43613
|
Multivitamins + Minerals
|
Centrum Advance
|
(See reverse for Formulation)
|
Film-Coated Tablet
|
Vitamins and Minerals
|
Wyeth Pharmaceutical Co. Ltd.
|
China
|
Renewal
|
18 March 2024
|
08 August 2029
|
| View |
|
DR-XY43614
|
Metformin Hydrochloride + Glibenclamide
|
Glycomet
|
500 mg/2.5 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
Pharmatec Pakistan (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
07 July 2024
|
11 August 2029
|
| View |
|
DR-XY43615
|
Metformin Hydrochloride + Glibenclamide
|
Glycomet Plus
|
500 mg/5 mg
|
Film-Coated Tablet
|
Oral Hypoglycemic
|
Pharmatec Pakistan (Pvt.) Ltd.
|
Pakistan
|
Renewal
|
10 June 2024
|
11 August 2029
|
| View |
|
DR-XY43619
|
Pantoprazole (as Sodium Sesquihydrate)
|
Opra-40
|
40 mg
|
Enteric-Coated Tablet
|
Proton Pump Inhibitor
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
19 April 2024
|
29 August 2029
|
| View |
DR-XY4362_PI_01.pdf
|
DR-XY4362
|
Iopromide
|
Ultravist
|
370mg/ mL
|
Solution for Injection (IV)
|
-
|
Bayer Pharma AG
|
Germany
|
Renewal
|
03 June 2021
|
25 June 2026
|
| View |
|
DR-XY43624
|
Ethambutol hydrochloride
|
Trabutol
|
400mg/5mL
|
Syrup
|
Anti-tuberculosis
|
Lloyd Laboratores, Inc.
|
Philippines
|
Renewal
|
23 August 2019
|
13 August 2029
|
| View |
|
DR-XY43625
|
Ethambutol hydrochloride
|
Trabutol
|
200mg/5mL
|
Syrup
|
Anti-tuberculosis
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
19 October 2023
|
13 August 2029
|
| View |
|
DR-XY43626
|
Theophylline
|
Nuelin
|
26.7mg/5mL syrup
|
Syrup
|
Bronchodilator
|
Ensign Laboratories Pty. Ltd.
|
Australia
|
Automatic Renewal
|
08 September 2022
|
15 August 2027
|
| View |
DR-XY4363_PI_01.pdf
|
DR-XY4363
|
Iopromide
|
Ultravist
|
300mg/mL
|
Solution For Injection (IV)
|
-
|
Bayer AG
|
Germany
|
-
|
22 February 2022
|
25 June 2026
|
| View |
|
DR-XY43631
|
Cefexime (as trihydrate)
|
Zefix
|
200 mg
|
Dispersible Tablet
|
Antibacterial
|
Baroque Pharmaceuticals Pvt. Ltd
|
India
|
Renewal
|
15 June 2024
|
15 August 2029
|
| View |
|
DR-XY43632
|
Cefixime ( as trihydrate)
|
Supixime -400
|
400 mg
|
Capsule
|
Antibacterial
|
Micro Labs Limited
|
India
|
Renewal
|
20 March 2024
|
15 August 2029
|